Match Column 1 with Column 2 :
| COLUMN 1 | COLUMN 2 |
| A. Biopiracy | i. Correction of a gene defect |
| B. Biopatent | ii. Emphysema |
| C. Gene therapy | iii. Illegal removal of biological materials. |
| D. α-1-antitrypsin | iv. Right granted for biological entities |
Answer & explanation
Correct answer: option 3
The correct answer is Option (3) - A-iii , B-iv, C-i, D-ii
| COLUMN 1 | COLUMN 2 |
| A. Biopiracy | iii. Illegal removal of biological materials. |
| B. Biopatent | iv. Right granted for biological entities |
| C. Gene therapy | i. correction of a gene defect |
| D. α-1-antitrypsin | ii. Emphysema |
Biopiracy – Illegal removal of biological materials:
Biopiracy refers to the unethical or unauthorized extraction of biological resources, often from indigenous communities or biodiversity-rich regions, for commercial use without compensating the rightful owners or countries of origin.
Biopatent – Right granted for biological entities:
A biopatent is a form of intellectual property protection granted to innovations involving biological materials, such as genes, microorganisms, or biological processes, giving the patent holder exclusive rights to use or commercialize the invention.
Gene therapy – correction of a gene defect:
Gene therapy is a collection of methods that allows correction of a gene defect that has been diagnosed in a child/embryo. Here genes are inserted into a person’s cells and tissues to treat a disease. Correction of a genetic defect involves delivery of a normal gene into the individual or embryo to take over the function of and compensate for the non-functional gene.
α-1-antitrypsin - Emphysema: Medicines required to treat certain human diseases can contain biological products, but such products are often expensive to make. Transgenic animals that produce useful biological products can be created by the introduction of the portion of DNA (or genes) which codes for a particular product such as human protein (α-1-antitrypsin) used to treat emphysema.